![]() | Only 14 pages are availabe for public view |
Abstract Infectious coryza (IC) is an acute highly contagious disease of chickens caused by Av. paragallinarum. The disease occurs worldwide and the reasons behind success of survival for this bacterium are that birds become carriers after recovering from infection. The economic impact of the disease is attributed to the resultant increase in unthrifty chickens and significant DROP in egg production (10 to 40%) in layer flocks and retardation of growth leading to increased number of culls particularly on multi-aged farms. In developing countries, the outcome of IC infection is more drastic and economic losses are much higher than those in developed ones In our study 120 field samples were collected from different poultry farms with a complain of rapid onset of clinical symptoms of nasal discharge, watery eyes, conjunctivitis, lacrimation, swelling of the sinuses and face, difficulty in breathing, anorexia, and swelling of wattles. Infected flocks suffered from decreased feed and water consumption and up-to 40% reduction in egg production in laying flocks. Through cultivation and biochemical identification, 12 samples gave positive results for IC of the total examined samples. Going through molecular diagnosis and confirmation, 9 isolates of these identified samples proved to be Av. paragallinarum, with an isolation rate of NADdependent isolates in our study of 7.5%. Molecular serotyping revealed that, 4 isolates were serovar A isolates, 3 isolates were serovar C, and 2 isolates were serovar B. The results of the current study further confirmed the co-circulation of the Av. paragallinarum serotypes A, B and C in Egypt. Moreover, the study further confirmed the reliability of using both conventional and Summary 133 multiplex PCR as a useful tool for fast diagnosis and serotyping of Av. paragallinarum isolates rather than laborious bacteriological isolation and identification techniques. Protection of chicken flocks against IC involves use of both vaccination and biosecurity. Vaccination is one of the most important means for controlling IC in chickens, and must be used to minimize the impact of IC, particularly in endemic areas. Hence, the current study was designed to prepare and evaluate an inactivated trivalent oil-emulsion based IC vaccine, using the locally identified Av. paragallinarum isolates (one serotype of each serovar A, B, and C), and comparing the efficacy of prepared vaccine with one of the commercially imported and approved trivalent IC vaccine. Firstly, the prepared vaccine was subjected to quality control measures assessment, and was proved to be of acceptable measures according to the protocols of the Egyptian Veterinary Codex 2009 CLEVB. Furthermore, this study went through identification and insurance of the safety and potency of the prepared vaccine. This was done through 4 experiments. This experimental part of the thesis was carried out on mixed developed baladi breed chickens purchased from layer farm, recognized to have no history of IC infection for long period. Chickens were purchased before introduction for IC vaccine regime in farm and confirmed to be seronegative for IC. The first experiment of our study was to assess the safety of the prepared vaccine. Our result demonstrated that both our locally prepared and the commercial used vaccine are good and of acceptable safety measures to be used for immunization of chickens. Summary 134 The second experiment was designed to assess the efficacy of vaccine after single dose and challenge subsequently three weeks after. Our results demonstrated that protection rate in chickens immunized with the trivalent locally prepared vaccine was 85.7%. It was higher than protection rate developed in chickens immunized with the trivalent commercial vaccine (73.8%). Also, it was observed that protection developed by the local prepared vaccine was clearly prominent particularly against challenge with serotype B and C. On the level of serotype, protection rate developed on use of the local prepared vaccine was 78.57%, 85.71%, and 92.86% against challenge with serotypes A, B, and C, respectively. While with the imported used vaccine, protection rate was 85.71%, 64.3%, and 71.43% against challenge with serotypes A, B, and C serotypes, respectively. The re-isolation rate was 12% from chickens vaccinated with the local prepared vaccine and challenged with Av. paragallinarum serotypes. While in chickens received the imported vaccine and challenged, re-isolation rate was 21%. On the other hand, the third experiment of our study, to assess efficacy of local prepared vaccine for protection against challenge with locally isolated serotypes of Av. paragallinarum after single and booster vaccination regimes with 4 weeks interval, We demonstrated that, the developed protection rate in chickens vaccinated with the locally prepared vaccine and challenged 3 weeks after booster dose was 95.2%, while it was 81% in the chickens vaccinated with the commercial vaccine. The overall protection rate was improved in third experiment following booster vaccination regime than single dose vaccination in second experiment. This improvement was obvious with the local prepared vaccine. As, protection rate elevated to 92.86% against Summary 135 challenging with serotypes A and B, and gave complete protection (100 %) against serotype C infection. While, booster dose in commercial vaccine resulted in slight improvement in protection against A and C serotypes, as it increased from 85.71% to 92.86% against challenge with serotype A, and from 71.43% to 78.57% against C serotype. While there was no improvement against B serotype infection and remained at 64.3%. Concerning re-isolation trials, the re-isolation rate was 4.8% in birds vaccinated with local prepared vaccine. While in birds received the commercial vaccine, re-isolation rate was 16.6%. So, with booster dose of the local prepared vaccine, the challenging bacteria was re-isolated from 2 birds instead of 5 birds with single dose vaccination with an improvement in immune response represented by rapid bacterial clearance from sinus by 60%. While with the commercial vaccine, the challenging bacteria was re-isolated from 9 birds after single dose vaccination and from 7 birds after booster dose vaccination with decreasing in possibility of colonization and replication of bacteria by 21%. The fourth experiment of our study was to evaluate immunogenicity of the local prepared vaccine, and to investigate the duration of provided protection using ELISA test. We found that, the level of antibody titers were weekly increased in vaccinated chickens either with the locally prepared vaccine or the commercial one, with a prominent higher antibody titer in chicken vaccinated with the local vaccine. The average antibody titer of the group vaccinated with local prepared vaccine was higher than the group vaccinated with commercial imported vaccine. Moreover, overall mean changes of antibody titer of Summary 136 local prepared vaccine is significantly high (P=0.0001) compared to those of commercial vaccine. We can conclude that, there were improvement in the protection and immunity of birds on vaccination with the locally developed vaccine while the commercial used vaccine did not react with the same efficacy against challenge with the locally isolated serotype of Av. paragallinarum. Hence, studies concerned with control IC disease should be conducted to characterize Av. paragallinarum isolates countrywide for the production of the corresponding autogenous vaccines. In conclusion the ability to protect birds through vaccination confirms the need for well-structured vaccination programs. The present study highlights the importance of a suitable vaccine formulation that generates protection throughout the productive life of chickens and the need for incorporation of local dominant strains in the vaccine. |